Teleflex Incorporated
TFXHealthcare·Medical Instruments & Supplies·USA·Mid·NYSE·Nov 11 • 10:01 AM ET
155.17-0.13 (-0.08%)
2026-11-11 16:01 CET
Market cap
6,159.40 USD m
Revenue, TTM
2,255.36 USD m
Net income, TTM
304.64 USD m
Free cash flow, TTM
388.23 USD m
EPS diluted, TTM
8.23
P/E
18.85
Price
TFX against its 20, 50 and 200-day averages2050200beat
1.0% under 156.67 on 5 Nov 2026. Last 15 sessions, 20.1% high to low
Profile
TFX52-week range, 97% of the way up
100.18156.67
Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia Pacific. The Americas, EMEA, and Asia Pacific segments are involved in the design, manufacture, and distribution of medical devices primarily used in critical care and surgical applications and generally serve two end-markets: hospitals and healthcare providers, and home health. The company was founded in 1943 and is headquartered in Wayne, PA.
| Index | RUI |
|---|---|
| Employees | 15500 |
| IPO | Apr 24, 1967 |
| Beta | 0.81 |
| ATR, 14d | 4.54 |
| Rel volume | 0.17 |
| Short float | 10.34% |
| Insider own | 0.85% |
| Inst own | 121.03% |
Snapshot
6 groupsValuation
| Index | RUI |
|---|---|
| Market Cap | 6.15B |
| Enterprise Value | 7.39B |
| Income | 304.64M |
| Sales | 2.26B |
| Book/sh | 86.30 |
| Cash/sh | 11.07 |
| Dividend Est. | 1.35 (0.87%) |
| Dividend TTM | 1.36 (0.88%) |
| Dividend Ex-Date | Nov 16, 2026 |
| Dividend Gr. 3/5Y | 0.00% 0.00% |
| Payout | - |
| Employees | 15500 |
| IPO | Apr 24, 1967 |
Ratios
| P/E | 18.85 |
|---|---|
| Forward P/E | 14.18 |
| PEG | 0.71 |
| P/S | 2.73 |
| P/B | 1.80 |
| P/C | 14.01 |
| P/FCF | 15.85 |
| EV/EBITDA | 18.44 |
| EV/Sales | 3.28 |
| Quick Ratio | 1.59 |
| Current Ratio | 2.01 |
| Debt/Eq | 0.48 |
| LT Debt/Eq | 0.46 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | 8.23 |
|---|---|
| EPS next Y | 10.94 |
| EPS next Q | 1.94 |
| EPS this Y | 9.96% |
| EPS next Y | 42.58% |
| EPS next 5Y | 19.94% |
| EPS past 3/5Y | - - |
| Sales past 3/5Y | -10.62% -4.72% |
| EPS Y/Y TTM | 213.16% |
| Sales Y/Y TTM | -29.30% |
| EPS Q/Q | 341.03% |
| Sales Q/Q | -37.81% |
| Earnings | Nov 05 BMO |
| EPS/Sales Surpr. | 38.13% 0.40% |
Ownership
| Insider Own | 0.85% |
|---|---|
| Insider Trans | 0.00% |
| Inst Own | 121.03% |
| Inst Trans | -2.87% |
| ROA | 1.23% |
| ROE | 2.40% |
| ROIC | 5.99% |
| Gross Margin | 65.25% |
| Oper. Margin | 12.37% |
| Profit Margin | 13.51% |
| SMA20 | 10.15% |
| SMA50 | 16.68% |
| SMA200 | 22.17% |
| Trades | - |
Technical
| Shs Outstand | 40.48M |
|---|---|
| Shs Float | 39.32M |
| Short Float | 10.34% |
| Short Ratio | 5.39 |
| Short Interest | 4.07M |
| 52W High | 156.67 -0.96% |
| 52W Low | 100.18 54.89% |
| Volatility | 4.67% 3.22% |
| ATR (14) | 4.54 |
| RSI (14) | 79.20 |
| Beta | 0.81 |
| Rel Volume | 0.17 |
| Avg Volume | 754.46K |
| Volume | 16,415 |
Performance
| Perf Week | 3.54% |
|---|---|
| Perf Month | 24.69% |
| Perf Quarter | 12.96% |
| Perf Half Y | 19.32% |
| Perf YTD | 27.15% |
| Perf Year | 38.22% |
| Perf 3Y | -22.43% |
| Perf 5Y | -54.13% |
| Perf 10Y | 8.46% |
| Recom | 2.27 |
| Target Price | 168.09 |
| Prev Close | 155.30 |
| Price | 155.17 |
| Change % | -0.08% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Sep 28, 2026 | Upgrade | BBofA Securities | Neutral → Buy | $158 | +1.8% |
| Jul 28, 2026 | Initiated | UUBS | Neutral | $145 | -6.6% |
| Jul 09, 2026 | Initiated | BBMO Capital Markets | Outperform | $159 | +2.5% |
| Jun 08, 2026 | Upgrade | PPiper Sandler | Neutral → Overweight | $160 | +3.1% |
| May 08, 2026 | Upgrade | RRBC Capital Mkts | Sector Perform → Outperform | $155 | -0.1% |
| Apr 13, 2026 | Upgrade | BBofA Securities | Underperform → Neutral | $135 | -13.0% |
| Mar 27, 2026 | Upgrade | RRaymond James | Mkt Perform → Outperform | $128 | -17.5% |
| Jan 27, 2026 | Upgrade | NNeedham | Hold → Buy | $138 | -11.1% |
| Mar 04, 2025 | Downgrade | BBofA Securities | Neutral → Underperform | $235 → $140 | -9.8% |
| Feb 28, 2025 | Downgrade | RRBC Capital Mkts | Outperform → Sector Perform | $220 → $155 | -0.1% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| BDX | Becton Dickinson & Co | 58.10B |
| MMSI | Merit Medical Systems Inc | 5.25B |
| ICUI | ICU Medical Inc | 4.54B |
| ANGO | Angiodynamic Inc | 509.28M |
| BAX | Baxter International Inc | 13.62B |
| LMAT | Lemaitre Vascular Inc | 1.82B |
| BSX | Boston Scientific Corp | 65.12B |
| CNMD | Conmed Corp | 1.52B |
| MDT | Medtronic Plc | 128.64B |
| ABT | Abbott Laboratories | 190.30B |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IJR | iShares Core S&P Small-Cap ETF | AUM: 106.27B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 79.59B |
| VBR | Vanguard Morningstar Small-Cap Value ETF | AUM: 37.76B |
| SPSM | State Street SPDR Portfolio S&P 600TM Small Cap ETF | AUM: 16.06B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.47B |
| IJS | iShares S&P Small-Cap 600 Value ETF | AUM: 7.74B |
| DFAS | U.S. Small Cap Portfolio-ETF Class Shares | - |
| DFSV | US Small Cap Value Portfolio ETF Class Shares | - |
| SLYV | State Street SPDR S&P 600 TM Small Cap Value ETF | AUM: 5.01B |
News
latest 14 of 103- Teleflex to Present at the Jefferies Global Healthcare Conference in London (Business Wire)
- Teleflex Crushes EPS Estimates And Raises Guidance Again, But Slowing Top Line, A Thin Q4 Outlook And Divestiture Timing Cloud The Setup (Earnings Whispers)
- Teleflex: Q3 Earnings Snapshot (Associated Press)
- Teleflex Announces Quarterly Dividend (Business Wire)
- Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook (Business Wire)
- Loading…
- Teleflex Faces Interventional Integration Test As Buybacks Prop Up Raised Earnings Outlook (Earnings Whispers)
- Teleflex Announces FDA Breakthrough Device Designation for Freesolve Resorbable Magnesium Scaffold (Business Wire)
- Teleflex Announces Third Quarter 2026 Earnings Conference Call Information (Business Wire)
- Enrollment Completed in BIOMAG-LL Clinical Study Evaluating Longer Lengths for Freesolve Resorbable Magnesium Scaffold (Business Wire)
- Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard Technology (Business Wire)
- Roblox downgraded, Royal Caribbean upgraded: Wall Street's top analyst calls (The Fly)
- Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors (Business Wire)
- Teleflex Features Innovative Dynetic-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026 (Business Wire)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-05 | 2.630 | 1.904 | 1.310 | 567.8 | 565.52 | 12 |
| 2026Q2 | 2026-08-06 | 1.760 | 1.281 | 2.283 | 570.3 | 559.59 | 13 |
| 2026Q1 | 2026-05-07 | 1.390 | 1.214 | -0.184 | 548.26 | 536.91 | 11 |
| 2025Q4 | 2026-02-26 | 1.930 | 3.760 | -16.147 | 569 | 919.31 | 11 |
| 2025Q3 | 2025-11-06 | 3.670 | 3.410 | -9.243 | 892.9 | 892.84 | 12 |
| 2025Q2 | 2025-07-31 | 3.730 | 3.363 | 2.765 | 780.9 | 771.55 | 12 |
| 2025Q1 | 2025-05-01 | 2.910 | 2.884 | 2.069 | 700.67 | 699.33 | 12 |
| 2024Q4 | 2025-02-27 | 3.890 | 3.862 | -2.947 | 795.4 | 813.21 | 12 |
| 2024Q3 | 2024-10-31 | 3.490 | 3.392 | 2.361 | 764.38 | 768.68 | 13 |
| 2024Q2 | 2024-08-01 | 3.420 | 3.332 | 1.690 | 763.5 | 762.98 | 14 |
| 2024Q1 | 2024-05-02 | 3.210 | 3.078 | 0.323 | 737.85 | 727.54 | 14 |
| 2023Q4 | 2024-02-22 | 3.380 | 3.264 | 0.658 | 773.91 | 768.72 | 14 |
| 2023Q3 | 2023-11-02 | 3.640 | 3.269 | 2.899 | 746.39 | 733.56 | 14 |
| 2023Q2 | 2023-08-03 | 3.410 | 3.207 | 2.352 | 743.26 | 729.87 | 15 |
| 2023Q1 | 2023-05-04 | 3.090 | 2.969 | 1.623 | 710.93 | 686.83 | 14 |
| 2022Q4 | 2023-02-23 | 3.520 | 3.442 | 1.664 | 758 | 760.35 | 15 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2019FY | 11.150 | 11.084 | 9.800 | 2,595 | 2,594 |
| 2020FY | 10.670 | 10.471 | 7.091 | 2,537 | 2,513 |
| 2021FY | 13.330 | 13.257 | 10.234 | 2,810 | 2,797 |
| 2022FY | 13.060 | 12.981 | 7.676 | 2,791 | 2,794 |
| 2023FY | 13.520 | 13.398 | 7.533 | 2,974 | 2,969 |
| 2024FY | 14.010 | 13.986 | 1.480 | 3,061 | 3,080 |
| 2025FY | 6.980 | 14.017 | -20.250 | 1,993 | 3,298 |
| 2026FY | - | 7.676 | - | - | 2,264 |
| 2027FY | - | 10.943 | - | - | 2,351 |
| 2028FY | - | 12.043 | - | - | 2,457 |
| 2029FY | - | 13.265 | - | - | 2,583 |
| 2030FY | - | 14.175 | - | - | 2,697 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-06 | 11 | 0 | 6 | 578.02 | 575 | 581.6 |
| 2026Q4 | S | 2026-11-05 | 11 | 0 | 5 | 578.7 | 575 | 585.32 |
| 2026Q4 | S | 2026-10-21 | 11 | 0 | 0 | 583.95 | 580 | 588.25 |
| 2026Q4 | S | 2026-10-20 | 11 | 0 | 1 | 583.95 | 580 | 588.25 |
| 2026Q4 | S | 2026-10-15 | 11 | 0 | 10 | 583.95 | 580 | 588.25 |
| 2026Q4 | S | 2026-10-12 | 12 | 0 | 11 | 584.24 | 580 | 588.25 |
| 2026Q4 | S | 2026-08-15 | 12 | 0 | 11 | 584.24 | 580 | 588.25 |
| 2026Q4 | S | 2026-08-07 | 13 | 0 | 11 | 585.37 | 580 | 599 |
| 2026Q4 | S | 2026-08-06 | 13 | 0 | 10 | 586.84 | 580 | 600 |
| 2026Q4 | S | 2026-07-27 | 13 | 0 | 0 | 598.45 | 588.25 | 603.7 |
| 2026Q4 | S | 2026-07-21 | 12 | 0 | 0 | 599.3 | 596.6 | 603.7 |
| 2026Q4 | S | 2026-07-10 | 12 | 0 | 3 | 599.3 | 596.6 | 603.7 |
| 2026Q4 | S | 2026-07-07 | 12 | 0 | 3 | 599.33 | 597 | 603.7 |
| 2026Q4 | S | 2026-07-01 | 11 | 0 | 3 | 599.18 | 597 | 603.7 |
Estimate history
| EPS, annual | 3.269 | 4.291 | 9.8 | 7.091 | 10.234 | 7.676 | 7.533 | 1.48 | -20.296 | 8.2307 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | 2.361 | -2.947 | 2.069 | 2.765 | -9.243 | -16.147 | -0.184 | 2.283 | 22.279 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 2146.303 | 2448.383 | 2595.362 | 2537.156 | 2809.563 | 2791.041 | 2974.489 | 1699.546 | 1992.713 | 2255.36 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 764.375 | 795.409 | 700.669 | 780.889 | 913.021 | 568.984 | 548.262 | 570.332 | 567.783 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 45.167 | 46.016 | 47.536 | 47.812 | 47.929 | 47.957 | 48.046 | 46.224 | 44.195 | 40.482 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 46.444 | 48.096 | 44.675 | 44.193 | 44.194 | 44.195 | 44.264 | 42.372 | 40.482 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,255.36 | 1,992.71 | 1,699.55 | 2,974.49 | 2,791.04 | 2,809.56 | 2,537.16 | 2,595.36 | 2,448.38 |
| Cost of Goods Sold Incl. D&A | 938.90 | 866.87 | 663.78 | 1,327.46 | 1,232.29 | 1,261.11 | 1,214.64 | 1,102.47 | 1,052.81 |
| Gross Profit | 1,471.61 | 1,125.85 | 1,035.76 | 1,647.03 | 1,558.76 | 1,548.45 | 1,322.52 | 1,492.90 | 1,395.57 |
| Selling, General and Administrative Excl. Other | 1,037.45 | 848.45 | 783.54 | 1,072.92 | 1,010.92 | 977.13 | 818.20 | 990.51 | 930.02 |
| Research and Development | 181.23 | 144.78 | 109.02 | 154.35 | 153.82 | 130.84 | 119.75 | 113.86 | 106.21 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 279.01 | 277.40 | 252.22 | 574.11 | 547.84 | 571.32 | 504.32 | 502.38 | 465.55 |
| Interest Expense | 133.06 | 120.35 | 102.55 | 116.13 | 75.14 | 76.27 | 80.99 | 80.27 | 103.02 |
| Unusual Expense | 65.44 | 156.93 | 17.46 | 27.00 | 58.60 | 48.52 | 83.61 | 88.74 | 147.51 |
| Net Income Before Taxes | 112.01 | 24.55 | 26.29 | 434.01 | 445.92 | 559.47 | 357.73 | 339.90 | 219.63 |
| Income Taxes | 24.35 | -33.98 | -30.90 | 76.44 | 83.00 | 74.35 | 21.93 | -122.08 | 23.20 |
| Consolidated Net Income | 87.66 | 58.53 | 57.19 | 357.57 | 362.92 | 485.12 | 335.80 | 461.98 | 196.43 |
| Net Income From Continuing Operations | 87.66 | 58.53 | 57.19 | 357.57 | 362.92 | 485.12 | 335.80 | 461.98 | 196.43 |
| Net Income | 304.64 | -905.64 | 69.67 | 356.33 | 363.14 | 485.37 | 335.32 | 461.47 | 200.80 |
| EPS (Recurring) | 8.42 | -17.83 | 1.74 | 7.93 | 8.54 | 10.95 | 8.33 | 11.12 | 6.50 |
| EPS (Basic, Before Extraordinaries) | 8.31 | -20.30 | 1.49 | 7.58 | 7.74 | 10.38 | 7.21 | 9.99 | 4.39 |
| EPS (Diluted) | 8.23 | -20.30 | 1.48 | 7.53 | 7.68 | 10.23 | 7.09 | 9.80 | 4.29 |
| EBITDA | 400.93 | 455.14 | 413.75 | 816.23 | 778.43 | 808.68 | 731.57 | 716.44 | 675.53 |
| Non-Operating Income (Expense) | 31.50 | 24.43 | -105.92 | 3.03 | 31.83 | 112.93 | 18.01 | 6.53 | 4.60 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 11.37 | 23.54 | 21.57 | 23.64 | 20.40 | 12.03 | -1.30 | 5.80 | 1.70 |
| Price To Earnings Ratio | 18.87 | 18.87 | 35.37 | 29.20 | 28.65 | 32.10 | 58.05 | 38.45 | 60.26 |
| Price To Sales Ratio | 2.31 | 2.73 | 4.93 | 3.97 | 4.23 | 5.54 | 7.67 | 6.83 | 4.94 |
| Gross Margin | 65.25 | 56.50 | 60.94 | 55.37 | 55.85 | 55.11 | 52.13 | 57.52 | 57.00 |
| Operating Margin | 12.37 | 13.92 | 14.84 | 19.30 | 19.63 | 20.33 | 19.88 | 19.36 | 19.01 |
| Net Margin | 13.51 | -45.45 | 4.10 | 11.98 | 13.01 | 17.28 | 13.22 | 17.78 | 8.20 |
| Shares Outstanding | 40.48 | 44.20 | 46.22 | 48.05 | 47.96 | 47.93 | 47.81 | 47.54 | 46.02 |
| Market Capitalization | 6,159.40 | 6,159.40 | 8,266.05 | 11,717.16 | 11,709.24 | 15,387.61 | 19,165.46 | 17,427.67 | 11,885.43 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 567.78 | 570.33 | 548.26 | 568.98 | 913.02 | 780.89 | 700.67 | 795.41 |
| Cost of Goods Sold Incl. D&A | 201.09 | 238.84 | 239.31 | 259.66 | 460.78 | 348.63 | 310.93 | 351.39 |
| Gross Profit | 366.69 | 331.49 | 308.95 | 309.33 | 452.24 | 432.25 | 389.74 | 444.01 |
| Selling, General and Administrative Excl. Other | 260.91 | 245.34 | 260.10 | 271.11 | 338.99 | 253.60 | 259.11 | 299.11 |
| Research and Development | 42.98 | 45.12 | 44.39 | 48.74 | 57.23 | 38.52 | 36.40 | 44.55 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 105.78 | 86.16 | 48.85 | 38.22 | 113.25 | 178.65 | 130.62 | 144.91 |
| Interest Expense | 28.94 | 35.07 | 34.02 | 35.02 | 37.61 | 24.95 | 21.20 | 22.94 |
| Unusual Expense | 5.74 | 10.70 | 25.64 | 23.37 | 522.15 | 24.57 | 5.05 | 255.29 |
| Net Income Before Taxes | 83.12 | 45.14 | -3.83 | -12.42 | -438.58 | 135.25 | 108.94 | -126.76 |
| Income Taxes | 28.84 | 3.38 | 1.01 | -8.87 | -29.70 | 12.66 | 13.84 | 9.90 |
| Consolidated Net Income | 54.29 | 41.76 | -4.84 | -3.55 | -408.88 | 122.58 | 95.10 | -136.66 |
| Net Income From Continuing Operations | 54.29 | 41.76 | -4.84 | -3.55 | -408.88 | 122.58 | 95.10 | -136.66 |
| Net Income | 927.43 | 99.69 | -8.15 | -714.33 | -408.89 | 122.58 | 95.00 | -136.66 |
| EPS (Recurring) | 22.38 | 2.45 | 0.22 | -15.78 | -0.98 | 3.15 | 2.15 | 0.91 |
| EPS (Basic, Before Extraordinaries) | 22.36 | 2.29 | -0.18 | -16.15 | -9.24 | 2.77 | 2.08 | -2.95 |
| EPS (Diluted) | 22.28 | 2.28 | -0.18 | -16.15 | -9.24 | 2.77 | 2.07 | -2.95 |
| EBITDA | 157.36 | 135.97 | 102.60 | 4.99 | 191.18 | 244.36 | 197.96 | 216.70 |
| Non-Operating Income (Expense) | 12.02 | 4.75 | 6.99 | 7.75 | 7.93 | 6.12 | 4.57 | 6.57 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 5.59 | 4.39 | 0.86 | 0.53 | 6.31 | 5.06 | 11.64 | 5.09 |
| Price To Earnings Ratio | 18.87 | - | - | - | 28.80 | 37.30 | 96.85 | 35.37 |
| Price To Sales Ratio | 2.31 | 2.13 | 1.88 | 1.82 | 1.66 | 1.74 | 2.10 | 2.71 |
| Gross Margin | 64.58 | 58.12 | 56.35 | 54.36 | 49.53 | 55.35 | 55.62 | 55.82 |
| Operating Margin | 18.63 | 15.11 | 8.91 | 6.72 | 12.40 | 22.88 | 18.64 | 18.22 |
| Net Margin | 163.34 | 17.48 | -1.49 | -125.54 | -44.78 | 15.70 | 13.56 | -17.18 |
| Shares Outstanding | 40.48 | 42.37 | 44.26 | 44.20 | 44.19 | 44.19 | 44.67 | 48.10 |
| Market Capitalization | 6,159.40 | 5,611.69 | 5,286.83 | 5,393.48 | 5,407.43 | 5,230.21 | 6,407.39 | 8,266.05 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 393.26 | 262.55 | 222.85 | 292.03 | 445.08 | 375.88 | 301.08 | 357.16 | 333.56 |
| Short Term Receivables | 345.58 | 226.73 | 443.47 | 408.83 | 383.57 | 395.07 | 418.67 | 366.29 | 345.88 |
| Inventories | 404.39 | 306.77 | 626.22 | 578.51 | 477.64 | 513.20 | 476.56 | 427.78 | 395.74 |
| Other Current Assets | 795.10 | 675.07 | 114.88 | 131.61 | 122.82 | 138.28 | 110.02 | 84.94 | 53.63 |
| Total Current Assets | 1,938.34 | 1,471.12 | 1,407.41 | 1,410.98 | 1,429.12 | 1,422.42 | 1,306.33 | 1,236.17 | 1,128.81 |
| Net Property, Plant & Equipment | 590.10 | 404.18 | 603.43 | 578.42 | 573.41 | 574.55 | 543.88 | 432.77 | 383.00 |
| Total Investments and Advances | 11.19 | 28.17 | 0.00 | 11.91 | 9.56 | 0.00 | 13.07 | 0.00 | 0.00 |
| Long-Term Note Receivable | - | - | - | - | - | 0.90 | 4.50 | 2.70 | 3.30 |
| Intangible Assets | 3,829.20 | 3,340.60 | 5,416.02 | 4,842.90 | 4,793.27 | 5,105.71 | 4,401.59 | 4,571.63 | 4,619.34 |
| Deferred Tax Assets | 12.59 | 9.29 | 6.75 | 6.40 | 6.82 | 8.07 | 5.57 | 2.45 | 3.81 |
| Other Assets | 565.82 | 1,844.56 | 98.94 | 77.45 | 59.54 | 40.90 | 34.88 | 32.28 | 43.24 |
| Total Assets | 6,947.24 | 7,097.91 | 7,532.55 | 6,928.06 | 6,871.72 | 7,152.56 | 6,309.82 | 6,277.99 | 6,181.49 |
| Short Term Debt Incl. Current Port. of LT Debt | 100.00 | 100.00 | 107.00 | 106.96 | 132.13 | 123.15 | 70.85 | 86.62 | 86.62 |
| Accounts Payable | 130.20 | 97.86 | 132.25 | 126.81 | 118.24 | 102.52 | 102.92 | 106.71 | 92.03 |
| Income Tax Payable | 18.79 | 41.16 | 41.45 | 24.74 | 83.94 | 17.36 | 6.69 | 5.94 | 11.51 |
| Other Current Liabilities | 513.04 | 410.34 | 326.04 | 322.99 | 345.81 | 297.00 | 382.60 | 383.18 | 293.71 |
| Total Current Liabilities | 762.03 | 649.36 | 606.75 | 581.49 | 680.12 | 540.03 | 563.05 | 582.46 | 483.88 |
| Long Term Debt | 2,625.66 | 1,643.83 | 1,838.87 | 1,744.46 | 1,856.13 | 2,463.99 | 1,960.32 | 2,072.20 | 2,162.93 |
| Provision for Risks Charges | 6.74 | 5.23 | 31.16 | 40.40 | 57.93 | 105.92 | 171.03 | 103.63 | 133.71 |
| Deferred Tax Liabilities | 183.75 | 295.45 | 456.08 | 388.89 | 370.12 | 484.68 | 439.56 | 608.22 | 603.68 |
| Other Liabilities | 244.30 | 225.90 | 158.70 | 150.86 | 152.66 | 221.50 | 196.54 | 371.50 | 366.78 |
| Total Liabilities | 3,822.47 | 2,819.77 | 3,091.56 | 2,906.09 | 3,116.97 | 3,816.10 | 3,330.50 | 3,738.01 | 3,750.96 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 3,124.77 | 4,278.14 | 4,440.99 | 4,021.97 | 3,754.75 | 3,336.46 | 2,979.32 | 2,539.98 | 2,430.53 |
| Total Shareholders Equity | 3,124.77 | 4,278.14 | 4,440.99 | 4,021.97 | 3,754.75 | 3,336.46 | 2,979.32 | 2,539.98 | 2,430.53 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 3,124.77 | 4,278.14 | 4,440.99 | 4,021.97 | 3,754.75 | 3,336.46 | 2,979.32 | 2,539.98 | 2,430.53 |
| Total Liabilities & Stockholders Equity | 6,947.24 | 7,097.91 | 7,532.55 | 6,928.06 | 6,871.72 | 7,152.56 | 6,309.82 | 6,277.99 | 6,181.49 |
| Book Value Per Share | 70.70 | 92.55 | 92.43 | 83.87 | 78.34 | 69.78 | 62.68 | 55.20 | 53.81 |
| Tangible Book Value Per Share | -15.94 | 20.28 | -20.29 | -17.12 | -21.67 | -37.00 | -29.92 | -44.15 | -48.46 |
| Full-Time Employees | 15,500 | 14,100 | 14,500 | 15,500 | 14,000 | 14,000 | 14,400 | 15,200 | 14,400 |
| Price to Book Ratio | 1.80 | 1.84 | 2.72 | 3.01 | 4.19 | 5.90 | 6.01 | 4.68 | 4.53 |
| Return on Assets | 0.83 | 0.78 | 4.95 | 5.26 | 6.92 | 4.99 | 7.34 | 3.15 | 3.08 |
| Return on Equity | 1.58 | 1.31 | 8.45 | 9.33 | 13.68 | 10.63 | 16.74 | 7.90 | 6.80 |
| Return on Invested Capital | -15.75 | 1.18 | 5.67 | 6.30 | 8.65 | 5.78 | 9.34 | 4.35 | 3.32 |
| Quick Ratio | 2.01 | 1.79 | 1.29 | 1.43 | 1.40 | 1.68 | 1.47 | 1.39 | 1.51 |
| Current Ratio | 2.54 | 2.27 | 2.32 | 2.43 | 2.10 | 2.63 | 2.32 | 2.12 | 2.33 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 304.64 | -905.64 | 69.67 | 356.33 | 363.14 | 485.37 | 335.32 | 461.47 | 200.80 |
| Depreciation | 121.92 | 177.74 | 161.53 | 242.12 | 230.59 | 237.36 | 227.25 | 214.06 | 209.98 |
| Other Funds (Non Cash) | -72.96 | 1,250.63 | 497.45 | 37.01 | 2.05 | -87.70 | -115.04 | 44.63 | 76.99 |
| Funds from Operations | 292.84 | 421.76 | 615.46 | 622.41 | 582.77 | 524.79 | 414.86 | 551.56 | 481.68 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 150.48 | -81.09 | 20.28 | -111.77 | -239.96 | 127.34 | 22.28 | -114.50 | -44.30 |
| Income Taxes Payable | - | - | -27.11 | - | - | - | - | - | - |
| Cash from Operating Activities | 443.32 | 340.68 | 635.74 | 510.64 | 342.81 | 652.14 | 437.14 | 437.07 | 437.38 |
| Capital Expenditures | -55.09 | -95.24 | -90.44 | -91.44 | -79.19 | -71.62 | -90.69 | -102.69 | -80.80 |
| Net Assets From Acquisitions | 1.31 | -831.86 | -0.12 | -603.92 | -198.43 | -4.59 | -767.83 | -3.46 | -121.03 |
| Sale of Fixed Assets and Businesses | 0.00 | 6.71 | 0.00 | 15.00 | 12.43 | 224.91 | 1.40 | 14.35 | 0.00 |
| Purchase or Sale of Investments | -8.98 | -5.00 | 0.00 | -4.00 | -15.00 | -11.12 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | -9.00 | -5.00 | -7.30 | -11.30 | -22.30 | -18.42 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.02 | 0.00 | 7.30 | 7.30 | 7.30 | 7.30 | 0.00 | 0.00 | 0.00 |
| Other Uses | -74.85 | -36.54 | -36.00 | 0.00 | - | -0.72 | -0.74 | - | 0.00 |
| Other Sources | 1,496.04 | 112.73 | 27.20 | 63.13 | 21.58 | 19.15 | 19.34 | 20.79 | 5.43 |
| Cash from Investing Activities | 1,358.44 | -849.19 | -99.36 | -621.23 | -258.61 | 156.02 | -838.52 | -71.02 | -196.39 |
| Cash Dividends Paid | -58.77 | -60.27 | -63.54 | -63.90 | -63.79 | -63.65 | -63.22 | -62.83 | -62.16 |
| Change in Capital Stock | -557.75 | -300.00 | -200.00 | 0.00 | 0.00 | 11.10 | 0.00 | 21.21 | 0.00 |
| Repurchase of Common Pref Stock | -557.75 | -300.00 | -200.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.10 | 0.00 | 21.21 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.10 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -1,054.34 | 982.04 | -161.50 | 101.25 | -145.45 | -644.27 | 566.56 | -253.50 | -93.50 |
| Change in Long Term Debt | -1,054.34 | 982.04 | -161.50 | 101.25 | -145.45 | -644.27 | 566.56 | -253.50 | -93.50 |
| Issuance of Long Term Debt | 2,345.04 | 1,135.04 | 130.00 | 646.00 | 739.05 | 390.23 | 1,505.37 | 275.00 | 35.00 |
| Reduction of Long Term Debt | -3,399.38 | -153.00 | -291.50 | -544.75 | -884.50 | -1,034.50 | -938.81 | -528.50 | -128.50 |
| Net Financing Active Other Cash Flow | -32.01 | -10.23 | 3.12 | 1.19 | -8.27 | -19.00 | -48.18 | -123.71 | -50.77 |
| Other Financing Activities Uses | -32.02 | -17.40 | -0.24 | -4.00 | -8.27 | -31.45 | -67.17 | -123.71 | -73.42 |
| Cash from Financing Activities | -1,702.87 | 611.54 | -421.93 | 38.54 | -217.51 | -715.82 | 455.16 | -418.84 | -206.43 |
| Exchange Rate Effect | -2.69 | 23.17 | -9.65 | 2.86 | -19.74 | -23.13 | 21.01 | -3.29 | -10.95 |
| Net Change in Cash | 96.20 | 126.20 | 104.80 | -69.19 | -153.05 | 69.20 | 74.80 | -56.08 | 23.60 |
| Free Cash Flow | 388.23 | 245.44 | 545.30 | 419.20 | 263.62 | 580.52 | 346.45 | 334.37 | 356.58 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 15.80 | 29.41 | 17.40 | 33.20 | 59.10 | 30.14 | 68.71 | 65.28 | 41.09 |
| Deferred Taxes & Investment Tax Credit | - | -100.97 | -113.21 | -13.05 | -13.01 | -110.24 | -32.67 | -168.59 | -6.10 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 439.14 | 314.86 | 324.11 | 393.26 | 368.70 | 268.40 |
| Short Term Receivables | 379.64 | 364.61 | 365.53 | 345.58 | 592.65 | 513.81 |
| Inventories | 384.42 | 351.91 | 380.86 | 404.39 | 802.47 | 693.69 |
| Other Current Assets | 641.48 | 844.50 | 789.17 | 795.10 | 222.17 | 247.97 |
| Total Current Assets | 1,844.67 | 1,875.88 | 1,859.67 | 1,938.34 | 1,985.98 | 1,723.86 |
| Net Property, Plant & Equipment | 544.04 | 552.79 | 561.87 | 590.10 | 807.64 | 648.06 |
| Total Investments and Advances | 8.52 | 4.98 | 8.68 | 11.19 | 13.56 | 15.53 |
| Intangible Assets | 3,693.07 | 3,741.10 | 3,783.33 | 3,829.20 | 4,948.18 | 4,878.36 |
| Deferred Tax Assets | 12.77 | 12.64 | 12.21 | 12.59 | 13.51 | 12.87 |
| Other Assets | 244.79 | 599.38 | 557.25 | 565.82 | 103.07 | 96.54 |
| Total Assets | 6,347.86 | 6,786.78 | 6,783.00 | 6,947.24 | 7,871.94 | 7,375.22 |
| Short Term Debt Incl. Current Port. of LT Debt | 87.50 | 87.50 | 103.12 | 100.00 | 100.00 | 100.00 |
| Accounts Payable | 142.87 | 143.29 | 143.63 | 130.20 | 165.91 | 157.56 |
| Income Tax Payable | 194.64 | 17.79 | 11.82 | 18.79 | 12.97 | 22.49 |
| Other Current Liabilities | 492.10 | 471.80 | 469.47 | 513.04 | 494.15 | 436.10 |
| Total Current Liabilities | 917.10 | 720.38 | 728.05 | 762.03 | 773.03 | 716.15 |
| Long Term Debt | 1,592.24 | 2,785.05 | 2,582.59 | 2,625.66 | 2,669.15 | 1,895.15 |
| Provision for Risks Charges | 4.28 | 7.00 | 6.93 | 6.74 | 37.90 | 23.95 |
| Deferred Tax Liabilities | 168.57 | 146.14 | 169.43 | 183.75 | 423.65 | 373.95 |
| Other Liabilities | 171.95 | 223.67 | 211.57 | 244.30 | 146.34 | 123.14 |
| Total Liabilities | 2,854.14 | 3,882.24 | 3,698.57 | 3,822.47 | 4,050.08 | 3,132.35 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 3,493.72 | 2,904.53 | 3,084.44 | 3,124.77 | 3,821.86 | 4,242.87 |
| Total Shareholders Equity | 3,493.72 | 2,904.53 | 3,084.44 | 3,124.77 | 3,821.86 | 4,242.87 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 3,493.72 | 2,904.53 | 3,084.44 | 3,124.77 | 3,821.86 | 4,242.87 |
| Total Liabilities & Stockholders Equity | 6,347.86 | 6,786.78 | 6,783.00 | 6,947.24 | 7,871.94 | 7,375.22 |
| Book Value Per Share | 86.30 | 68.55 | 69.68 | 70.70 | 86.48 | 96.01 |
| Tangible Book Value Per Share | -4.92 | -19.74 | -15.79 | -15.94 | -25.49 | -14.38 |
| Full-Time Employees | - | - | - | 15,500 | - | - |
| Price to Book Ratio | 1.80 | 1.82 | 1.69 | 1.41 | 1.27 | 1.29 |
| Return on Assets | 1.23 | -5.30 | -4.23 | -2.77 | -4.27 | 2.59 |
| Return on Equity | 2.40 | -10.51 | -8.21 | -5.26 | -7.90 | 4.36 |
| Return on Invested Capital | 18.24 | 1.75 | -0.14 | -12.42 | -6.30 | 2.00 |
| Quick Ratio | 1.59 | 2.12 | 2.03 | 2.01 | 1.53 | 1.44 |
| Current Ratio | 2.01 | 2.60 | 2.55 | 2.54 | 2.57 | 2.41 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 927.43 | 99.69 | -8.15 | -714.33 | -408.89 | 122.58 |
| Depreciation | 51.58 | 49.82 | 53.74 | -33.23 | 77.92 | 65.71 |
| Other Funds (Non Cash) | -822.10 | -55.01 | 6.52 | 797.63 | 511.18 | -37.36 |
| Funds from Operations | 174.17 | 91.12 | 39.40 | -11.85 | 143.10 | 148.63 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -26.41 | 3.21 | 9.62 | 164.06 | -35.47 | -140.89 |
| Cash from Operating Activities | 147.76 | 94.33 | 49.02 | 152.21 | 107.63 | 7.74 |
| Capital Expenditures | -21.61 | -14.03 | -18.79 | -0.65 | -29.95 | -34.63 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 1.31 | -826.47 | -6.61 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 6.71 | 0.00 |
| Purchase or Sale of Investments | 0.02 | -6.50 | -2.50 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | -6.50 | -2.50 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 19.38 | 5.02 | -62.71 | -36.54 | 0.00 | 0.00 |
| Other Sources | 1,482.58 | 0.00 | 0.00 | 13.47 | 82.20 | 10.75 |
| Cash from Investing Activities | 1,480.36 | -15.51 | -84.00 | -22.41 | -767.50 | -30.49 |
| Cash Dividends Paid | -13.92 | -14.78 | -15.05 | -15.03 | -15.02 | -15.03 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -304.95 | -252.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | -304.95 | -252.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -1,193.12 | 200.25 | -25.25 | -36.21 | 773.62 | -6.25 |
| Change in Long Term Debt | -1,193.12 | 200.25 | -25.25 | -36.21 | 773.62 | -6.25 |
| Issuance of Long Term Debt | 0.00 | 2,350.00 | 0.00 | -4.96 | 840.00 | 0.00 |
| Reduction of Long Term Debt | -1,193.12 | -2,149.75 | -25.25 | -31.25 | -66.38 | -6.25 |
| Net Financing Active Other Cash Flow | -2.28 | -14.67 | -4.68 | -10.37 | -2.26 | -2.39 |
| Other Financing Activities Uses | -2.28 | -14.67 | -4.68 | -10.38 | -2.21 | -2.25 |
| Cash from Financing Activities | -1,514.28 | -82.00 | -44.98 | -61.61 | 756.34 | -23.67 |
| Exchange Rate Effect | -0.62 | -1.53 | -4.89 | 4.35 | 0.92 | 12.86 |
| Net Change in Cash | 113.22 | -4.71 | -84.85 | 72.54 | 97.39 | -33.56 |
| Free Cash Flow | 126.14 | 80.30 | 30.23 | 151.56 | 77.69 | -26.89 |
| Price to Free Cash Flow | 15.80 | 19.77 | 30.69 | 29.16 | 26.10 | 15.82 |
Revenue breakdown
| Interventional | 2024: 397.34M 2025: 647.79M |
|---|---|
| Other | 2024: -6.18M 2025: 9.04M |
| Surgical | 2024: 404.87M 2025: 418.16M |
| Vascular Access | 2024: 903.51M 2025: 917.73M |
| Asia and Asia Pacific | 2024: 179.57M 2025: 218.03M |
| Europe | 2024: 347.90M 2025: 484.73M |
| Other countries | 2024: 92.74M 2025: 108.13M |
| United States | 2024: 1.08B 2025: 1.18B |
| Americas | 2024: 1.16B 2025: 1.28B |
| Asia | 2024: 202.35M 2025: 241.11M |
| EMEA | 2024: 340.26M 2025: 472.41M |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 10.34% | 4.1M | 39.3M | 722.08K |
| 2026-10-15 | 10.04% | 4.2M | 42.0M | 675.87K |
| 2026-09-30 | 9.64% | 4.1M | 42.0M | 635.53K |
| 2026-09-15 | 9.53% | 4.0M | 42.0M | 544.22K |
| 2026-08-31 | 9.58% | 4.0M | 42.0M | 530.95K |
| 2026-08-14 | 11.50% | 4.8M | 42.0M | 556.26K |
| 2026-07-31 | 7.20% | 3.0M | 42.0M | 567.54K |
| 2026-07-15 | 6.34% | 2.8M | 43.9M | 709.76K |
| 2026-06-30 | 5.61% | 2.5M | 43.9M | 740.55K |
| 2026-06-15 | 5.26% | 2.3M | 43.9M | 803.38K |
| 2026-05-29 | 5.43% | 2.4M | 44.0M | 841.04K |
| 2026-05-15 | 5.41% | 2.4M | 44.0M | 913.74K |
| 2026-04-30 | 4.91% | 2.2M | 44.0M | 940.64K |
| 2026-04-15 | 5.52% | 2.4M | 44.0M | 905.29K |
| 2026-03-31 | 5.95% | 2.6M | 44.0M | 985.64K |
| 2026-03-13 | 5.21% | 2.3M | 44.0M | 929.95K |
| 2026-02-27 | 5.57% | 2.5M | 44.0M | 944.81K |
| 2026-02-13 | 5.56% | 2.4M | 44.0M | 854.63K |
| 2026-01-30 | 4.99% | 2.2M | 43.9M | 837.38K |
| 2026-01-15 | 4.33% | 1.9M | 43.9M | 731.89K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 75.00 | 77.60 | 82.00 | 0.00 | 3.189 | 0.00 | 0.00 | 0.945 | -0.518 | 0.027 |
| call | 80.00 | 72.60 | 77.00 | 0.00 | 2.944 | 0.00 | 0.00 | 0.941 | -0.511 | 0.029 |
| call | 85.00 | 67.60 | 72.00 | 0.00 | 2.714 | 0.00 | 0.00 | 0.936 | -0.503 | 0.031 |
| call | 90.00 | 62.60 | 67.00 | 0.00 | 2.497 | 0.00 | 0.00 | 0.931 | -0.494 | 0.033 |
| call | 95.00 | 57.50 | 62.00 | 0.00 | 2.290 | 0.00 | 0.00 | 0.925 | -0.485 | 0.035 |
| call | 100 | 52.60 | 57.00 | 0.00 | 2.094 | 0.00 | 0.00 | 0.918 | -0.474 | 0.037 |
| call | 105 | 47.60 | 52.00 | 0.00 | 1.905 | 0.00 | 0.00 | 0.911 | -0.463 | 0.039 |
| call | 110 | 42.60 | 47.00 | 0.00 | 1.724 | 0.00 | 0.00 | 0.902 | -0.450 | 0.042 |
| call | 115 | 37.60 | 42.00 | 0.00 | 1.549 | 0.00 | 0.00 | 0.893 | -0.436 | 0.045 |
| call | 120 | 32.60 | 37.00 | 0.00 | 1.381 | 0.00 | 0.00 | 0.836 | -0.667 | 0.060 |
| call | 125 | 27.60 | 32.00 | 30.19 | 1.216 | 168 | 0.00 | 0.819 | -0.637 | 0.064 |
| call | 130 | 22.80 | 27.50 | 20.80 | 1.119 | 172 | 0.00 | 0.800 | -0.604 | 0.069 |
| call | 135 | 18.20 | 22.50 | 18.00 | 0.979 | 130 | 0.00 | 0.829 | -0.356 | 0.062 |
| call | 140 | 13.60 | 17.50 | 6.20 | 0.807 | 19.00 | 0.00 | 0.743 | -0.516 | 0.079 |
| call | 145 | 9.00 | 12.50 | 4.50 | 0.636 | 283 | 0.00 | 0.708 | -0.430 | 0.084 |
| call | 150 | 4.50 | 8.50 | 2.38 | 0.566 | 1.00 | 0.00 | 0.645 | -0.355 | 0.091 |
| call | 155 | 0.70 | 5.20 | 0.00 | 0.517 | 0.00 | 0.00 | 0.527 | -0.315 | 0.097 |
| call | 160 | 0.00 | 4.90 | 0.00 | 0.719 | 0.00 | 0.00 | 0.409 | -0.373 | 0.095 |
| call | 165 | 0.00 | 4.90 | 2.40 | 0.849 | 450 | 0.00 | 0.349 | -0.389 | 0.094 |
| call | 170 | 0.00 | 4.90 | 0.00 | 1.002 | 0.00 | 0.00 | 0.319 | -0.463 | 0.091 |
| call | 175 | 0.00 | 4.90 | 0.30 | 1.141 | 5.00 | 0.00 | 0.294 | -0.514 | 0.088 |
| call | 180 | 0.00 | 4.90 | 0.00 | 1.269 | 0.00 | 0.00 | 0.274 | -0.551 | 0.085 |
| call | 185 | 0.00 | 4.90 | 0.00 | 1.388 | 0.00 | 0.00 | 0.257 | -0.584 | 0.082 |
| put | 75.00 | 0.00 | 4.90 | 0.00 | 3.268 | 0.00 | 0.00 | -0.052 | -0.448 | 0.027 |
| put | 80.00 | 0.00 | 4.90 | 0.00 | 3.022 | 0.00 | 0.00 | -0.056 | -0.442 | 0.029 |
| put | 85.00 | 0.00 | 4.90 | 0.00 | 2.790 | 0.00 | 0.00 | -0.061 | -0.435 | 0.031 |
| put | 90.00 | 0.00 | 4.90 | 0.00 | 2.572 | 0.00 | 0.00 | -0.066 | -0.427 | 0.033 |
| put | 95.00 | 0.00 | 4.90 | 0.00 | 3.119 | 0.00 | 0.00 | -0.107 | -0.770 | 0.045 |
| put | 100 | 0.00 | 4.90 | 0.00 | 2.874 | 0.00 | 0.00 | -0.116 | -0.752 | 0.048 |
| put | 105 | 0.00 | 4.90 | 0.00 | 2.640 | 0.00 | 0.00 | -0.126 | -0.731 | 0.051 |
| put | 110 | 0.00 | 4.90 | 2.23 | 1.908 | 1.00 | 0.00 | -0.098 | -0.441 | 0.042 |
| put | 115 | 0.00 | 4.90 | 3.35 | 1.722 | 1.00 | 0.00 | -0.107 | -0.426 | 0.045 |
| put | 120 | 0.00 | 4.90 | 1.60 | 1.541 | 3.00 | 0.00 | -0.119 | -0.410 | 0.049 |
| put | 125 | 0.00 | 4.90 | 1.00 | 1.364 | 428 | 0.00 | -0.132 | -0.391 | 0.052 |
| put | 130 | 0.00 | 4.90 | 3.30 | 1.581 | 1,269 | 0.00 | -0.200 | -0.593 | 0.069 |
| put | 135 | 0.00 | 2.45 | 3.70 | 1.375 | 402 | 0.00 | -0.225 | -0.552 | 0.074 |
| put | 140 | 0.00 | 4.90 | 2.00 | 1.180 | 100 | 0.00 | -0.256 | -0.507 | 0.079 |
| put | 145 | 0.05 | 4.90 | 6.50 | 0.969 | 451 | 0.00 | -0.292 | -0.417 | 0.084 |
| put | 150 | 0.35 | 4.90 | 0.00 | 0.755 | 0.00 | 0.00 | -0.355 | -0.342 | 0.091 |
| put | 155 | 1.80 | 6.00 | 0.00 | 0.630 | 0.00 | 0.00 | -0.473 | -0.301 | 0.097 |
| put | 160 | 4.40 | 9.00 | 0.00 | 0.656 | 0.00 | 0.00 | -0.583 | -0.350 | 0.096 |
| put | 165 | 8.50 | 13.00 | 0.00 | 0.710 | 0.00 | 0.00 | -0.649 | -0.415 | 0.091 |
| put | 170 | 13.00 | 17.80 | 0.00 | 0.836 | 0.00 | 0.00 | -0.680 | -0.488 | 0.088 |
| put | 175 | 18.00 | 22.80 | 0.00 | 0.970 | 0.00 | 0.00 | -0.706 | -0.538 | 0.084 |
| put | 180 | 23.10 | 27.90 | 0.00 | 1.094 | 0.00 | 0.00 | -0.727 | -0.578 | 0.081 |
| put | 185 | 28.00 | 32.80 | 0.00 | 1.210 | 0.00 | 0.00 | -0.743 | -0.613 | 0.079 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-05 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-05 | 8-K | Current report | 2026-11-05 | SEC |
| 2026-09-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-09-10 | 3 | Initial statement of beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-09-09 | 8-K | Current report | 2026-09-08 | SEC |
| 2026-09-08 | SCHEDULE 13G/A | SEC | ||
| 2026-08-14 | SCHEDULE 13G/A | SEC | ||
| 2026-08-07 | 8-K | Current report | 2026-08-07 | SEC |
| 2026-08-06 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-06 | 8-K | Current report | 2026-08-06 | SEC |
| 2026-08-05 | 8-K/A | 2026-08-03 | SEC | |
| 2026-08-03 | 8-K | Current report | 2026-08-03 | SEC |
| 2026-06-26 | 11-K | Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | 2025-12-31 | SEC |
| 2026-06-15 | 8-K | Current report | 2026-06-15 | SEC |
| 2026-06-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-07 | SEC |
| 2026-06-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-08 | SEC |
| 2026-06-09 | 3 | Initial statement of beneficial ownership of securities | 2026-06-08 | SEC |
| 2026-06-09 | 8-K | Current report | 2026-06-08 | SEC |
| 2026-06-02 | 8-K | Current report | 2026-06-01 | SEC |
| 2026-06-01 | 8-K | Current report | 2026-06-01 | SEC |
| 2026-05-28 | SD | Specialized Disclosure Report | SEC | |
| 2026-05-27 | 8-K | Current report | 2026-05-26 | SEC |
| 2026-05-20 | 8-K | Current report | 2026-05-15 | SEC |
| 2026-05-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-15 | SEC |
| 2026-05-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-15 | SEC |
| 2026-05-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-15 | SEC |
| 2026-05-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-15 | SEC |
| 2026-05-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-15 | SEC |
| 2026-05-19 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-15 | SEC |
| 2026-05-18 | 3 | Initial statement of beneficial ownership of securities | 2026-05-15 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 12.27% |
| Jupiter Topco LLC | 9.81% |
| T. Rowe Price Investment Management, Inc. | 7.22% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.46% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.51% |
| Sessa Capital IM, L.P. | 3.45% |
| STATE STREET CORP | 3.35% |
| MILLENNIUM MANAGEMENT LLC | 3.26% |
| BAUPOST GROUP LLC/MA | 3.18% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2.98% |
Funds
| Fund | % owned |
|---|---|
| High Yield Bond Series | 31.82% |
| NYLIM MacKay High Yield Corporate Bond Fund | 21.10% |
| NYLIM MacKay Short Duration High Income Fund | 16.94% |
| iShares Broad USD High Yield Corporate Bond ETF | 16.05% |
| State Street(R) SPDR(R) Portfolio High Yield Bond ETF | 14.85% |
| iShares iBoxx $ High Yield Corporate Bond ETF | 14.35% |
| Shenkman Capital Short Duration High Income Fund | 13.01% |
| Invesco BulletShares 2027 High Yield Corporate Bond ETF | 12.87% |
| VANGUARD HIGH-YIELD CORPORATE FUND | 11.87% |
| MFS High Income Fund | 11.50% |
OakChart. TFX. Cached 15 minutes.
Some panels did not load: insider.